BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 8751230)

  • 41. Reinfection or recrudescence after apparently successful eradication of Helicobacter pylori infection: implications for treatment of patients with duodenal ulcer disease.
    Bell GD; Powell KU; Burridge SM; Harrison G; Rameh B; Weil J; Gant PW; Jones PH; Trowell JE
    Q J Med; 1993 Jun; 86(6):375-82. PubMed ID: 8171185
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Treatment of Helicobacter pylori reduces the rate of rebleeding in peptic ulcer disease.
    Graham DY; Hepps KS; Ramirez FC; Lew GM; Saeed ZA
    Scand J Gastroenterol; 1993 Nov; 28(11):939-42. PubMed ID: 8284627
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Eradication of Helicobacter pylori and hemorrhagic recurrence of duodenal ulcer].
    Gisbert JP; Boixeda D; Hernández Ranz F; Martín de Argila C
    Rev Esp Enferm Dig; 1995 Dec; 87(12):910-1. PubMed ID: 8562204
    [No Abstract]   [Full Text] [Related]  

  • 44. Ulcer relapse rates following initial treatment with bismuth subnitrate as compared with cimetidine respectively.
    Topfmeier P; Eberhardt R; Mateblowski M; Kuhn D
    Int J Clin Pharmacol Ther Toxicol; 1991 Nov; 29(11):437-40. PubMed ID: 1800390
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Treatment of Helicobacter pylori infection in adults].
    Boixeda D
    Enferm Infecc Microbiol Clin; 1994 May; 12 Suppl 1():41-7. PubMed ID: 8054370
    [No Abstract]   [Full Text] [Related]  

  • 46. The role of Helicobacter pylori in gastroduodenal disease.
    Wang KK
    Compr Ther; 1991 Sep; 17(9):35-8. PubMed ID: 1769198
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A 1-h topical therapy for the treatment of Helicobacter pylori infection.
    Kimura K; Ido K; Saifuku K; Taniguchi Y; Kihira K; Satoh K; Takimoto T; Yoshida Y
    Am J Gastroenterol; 1995 Jan; 90(1):60-3. PubMed ID: 7801950
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [The role for Helicobacter pylori infection in intractable and recurrent ulcer].
    Kubota T; Ito A; Shiota K; Fujioka T
    Nihon Rinsho; 1993 Dec; 51(12):3221-6. PubMed ID: 8283637
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Helicobacter pylori in peptic ulcer disease.
    NIH Consens Statement; 1994 Feb 7-9; 12(1):1-23. PubMed ID: 7920747
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Quality of life and relapse of duodenal ulcer before and after eradication of Helicobacter pylori.
    Wilhelmsen I; Berstad A
    Scand J Gastroenterol; 1994 Oct; 29(10):874-9. PubMed ID: 7839092
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Helicobacter pylori eradication in patients with peptic ulcer disease: clinical consequences and financial implications.
    Powell KU; Bell GD; Bolton GH; Burridge SM; Bowden AF; Rameh B; Hart L; Bradley P; Harrison G; Gant PW
    Q J Med; 1994 May; 87(5):283-90. PubMed ID: 7938408
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Management of the peptic ulcer patient in the Helicobacter pylori age].
    Marshall BJ
    Enferm Infecc Microbiol Clin; 1994 May; 12 Suppl 1():36-40. PubMed ID: 7914434
    [No Abstract]   [Full Text] [Related]  

  • 53. The effect of Helicobacter pylori eradication on gastro-oesophageal reflux.
    Tefera S; Hatlebakk JG; Berstad A
    Aliment Pharmacol Ther; 1999 Jul; 13(7):915-20. PubMed ID: 10383526
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Importance of post-treatment follow-up to secure sufficient eradication therapy for Helicobacter pylori.
    Roug S; Madsen LG
    Dan Med J; 2012 Dec; 59(12):A4553. PubMed ID: 23290289
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Long-term endoscopic follow-up for peptic ulcer patients after eradication of H. pylori; comparison with the maintainance therapy by H2-blocker].
    Shirai T; Kurumada T; Kouda K; Asano K; Takagi A; Harasawa S; Miwa T
    Nihon Rinsho; 1999 Jan; 57(1):157-61. PubMed ID: 10036955
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Only four days of quadruple therapy can effectively cure Helicobacter pylori infection.
    De Boer WA; Driessen WM; Tytgat GN
    Aliment Pharmacol Ther; 1995 Dec; 9(6):633-8. PubMed ID: 8824650
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Patients with endoscopic gastritis and/or duodenitis improve markedly following eradication of Helicobacter pylori, although less so than patients with ulcers.
    Olafsson S; Hatlebakk JG; Berstad A
    Scand J Gastroenterol; 2002 Dec; 37(12):1386-94. PubMed ID: 12523587
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Six-year follow-up after successful triple therapy for Helicobacter pylori infection in patients with peptic ulcer disease.
    van der Wouden EJ; Thijs JC; van Zwet AA; Kleibeuker JH
    Eur J Gastroenterol Hepatol; 2001 Oct; 13(10):1235-9. PubMed ID: 11711782
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effects of omeprazole and eradication of Helicobacter pylori on gastric and duodenal mucosal enzyme activities and DNA in duodenal ulcer patients.
    Vetvik K; Schrumpf E; Mowinckel P; Aase S; Andersen KJ
    Scand J Gastroenterol; 1994 Nov; 29(11):995-1000. PubMed ID: 7871380
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Helicobacter pylori and peptic ulcer disease. Reexamining the therapeutic approach.
    Fedotin MS
    Postgrad Med; 1993 Sep; 94(3):38-40, 43-5. PubMed ID: 8361941
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.